Virpax Pharmaceuticals Inc. (VRPX)
NASDAQ (CM) NASDAQ (CM) Primary 
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
On Friday, Virpax Pharmaceuticals, Inc. VRPX completed the full study following the initial Probudur pilot study performed by the U.S. Army Institute of Surgical Research (USAISR) under an existing Cooperative Research and Development Agreement (CRADA).
Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 50 points on Wednesday.
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?
Virpax Pharmaceuticals (NASDAQ: VRPX ) stock is rocketing higher on Wednesday after the preclinical-stage pharmaceutical company announced positive results from a swine model pilot study. Virpax Pharmaceuticals has released results from its swine model study of Probudur.
Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
Wednesday, Virpax Pharmaceuticals Inc VRPX released results for a Swine Model pilot study for Probudur, Virpax's long-acting liposomal bupivacaine formulation injected at a wound site to provide immediate and extended pain relief.
What's Going With Penny Stock Virpax Pharmaceuticals On Monday?
Shares of Virpax Pharmaceuticals Inc VRPX are trading higher on Monday on a strong session volume of 22.8 million, as per data from Benzinga Pro.
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 97% Today?
Virpax Pharmaceuticals (NASDAQ: VRPX ) stock is heading higher on Monday after the preclinical-stage pharmaceutical company secured a new $2.5 million loan. Virpax Pharmaceuticals says that this funding comes from an institutional investor.
